Barclays
HCAT icon

Barclays’s Health Catalyst HCAT Stock Holding History

Barclays’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84K Sell
66,139
-82,047
-55% -$154K ﹤0.01% 4100
2025
Q4 		$354K Buy
148,186
+10,100
+7% +$27.6K ﹤0.01% 4047
2025
Q3 		$394K Sell
138,086
-17,915
-11% -$61.3K ﹤0.01% 3952
2025
Q2 		$588K Sell
156,001
-109,352
-41% -$430K ﹤0.01% 3669
2025
Q1 		$1.2M Buy
265,353
+90,546
+52% +$479K ﹤0.01% 2998
2024
Q4 		$1.24M Buy
174,807
+14,656
+9% +$117K ﹤0.01% 3232
2024
Q3 		$1.3M Buy
160,151
+56,369
+54% +$407K ﹤0.01% 3177
2024
Q2 		$663K Sell
103,782
-721
-0.7% -$4.63K ﹤0.01% 2855
2024
Q1 		$787K Sell
104,503
-23,522
-18% -$215K ﹤0.01% 3303
2023
Q4 		$1.19M Buy
128,025
+74,816
+141% +$611K ﹤0.01% 3310
2023
Q3 		$538K Buy
53,209
+30,580
+135% +$365K ﹤0.01% 2760
2023
Q2 		$283K Sell
22,629
-6,570
-23% -$78.2K ﹤0.01% 3080
2023
Q1 		$341K Buy
29,199
+12,729
+77% +$162K ﹤0.01% 3511
2022
Q4 		$175K Buy
16,470
+12,054
+273% +$116K ﹤0.01% 3911
2022
Q3 		$43K Sell
4,416
-20,071
-82% -$266K ﹤0.01% 3823
2022
Q2 		$354K Buy
24,487
+4,582
+23% +$78.1K ﹤0.01% 3093
2022
Q1 		$521K Buy
+19,905
New +$565K ﹤0.01% 2874

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays's HCAT Position: Q1 2026 in Review

Barclays reduced its Health Catalyst (HCAT) stake by 55% in Q1 2026, selling an estimated $154K and leaving 66,139 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #4100.

Barclays first reported a position in HCAT in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.3M in Q3 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Barclays held 66,139 shares of Health Catalyst worth $84K as of Q1 2026.
  • Barclays sold 82,047 Health Catalyst shares in Q1 2026, an estimated $154K.
  • Health Catalyst made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4100 holding.
  • Barclays first reported a position in Health Catalyst in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Health Catalyst position peaked at $1.3M in Q3 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.